St. Jude Relying On ICD Boom To Weather Slowdown In Pacer Sales
This article was originally published in The Gray Sheet
Executive Summary
St. Jude continues to benefit from the rapidly expanding ICD market, although pacemaker sales are constrained by competition from cardiac resynchronization therapy (CRT) devices for congestive heart failure